Efficacy of Getong Tongluo Capsule(葛酮通络胶嚢)for Convalescent-Phase of Ischemic Stroke and Primary Hypertension:A Multicenter,Randomized,Double-Blind,Controlled Trial |
| |
作者姓名: | ZHAO Qian-yu TANG Rong-hu LU Guo-xiong CHEN Zhi-gang |
| |
作者单位: | Department of neurology;the second school of clinical medicine;Department of neurology;Department of neurology;Department of neurology;Department of neurology;Department of neurology;Department of neurology;Department of neurology;Department of neurology;i 9.Department of neurology;Department of neurosurgery;Department of neurology;Department of neurology;Department of neurology;Department of rehabilitation;Department of neurology;Department of neurology;Department of neurology |
| |
基金项目: | Supported by the project of Guangzhou Clinical Medical Research and Transformation Center Pilot Construction(No.20160402003)。 |
| |
摘 要: | Objective:To evaluate whether the efficacy of Getong Tongluo Capsule(葛酮通络胶囊,GTC,consisted of total flavone of Radix Puerariae)on improving patients'quality of life and lowering blood pressure are superior to the extract of Ginkgo biloba(EGB)for patients with convalescent-phase ischemic stroke and primary hypertension.Methods:This randomized,positive-drug-and placebo-controlled,double-blind trial was conducted from September 2015 to October 2017.Totally 477 eligible patients from 18 hospitals in China were randomly assigned in a 2:1:1 ratio to the following interventions,twice a day for 12 weeks:(1)GTC 250 mg plus EGB-matching placebo 40 mg(237 cases,GTC group),(2)EGB 40 mg plus GTC-matching placebo 250 mg(120 cases,EGB group)or(3)GTC-matching placebo 250 mg plus EGB-matching placebo 40 mg(120 cases,placebo group).Moreover,all patients were orally administered aspirin enteric-coated tablets 100 mg,once a day fo r 12 weeks.The primary outcome was the Barthel Index(Bl).The secondary outcomes included the control rate of blood pressure and National Institutes of Health Stroke Scale(NIHSS)scores.The incidence and severity of adverse events(AEs)were calculated and assessed.Results:The Bl relative independence rates,the clinical recovery rates of NIHSS,and the total effective rates of NIHSS in the GTC and EGB groups were significantly higher than the placebo group at 12 weeks after treatment(P<0.05),and no statistical significance was found between the GTC and EGB groups(P>0.05).The control rate of blood pressure in the GTC group was significantly higher than the EGB and placebo groups at 12,18 and 24 weeks after treatment(P<0.01).There were no statistically significant differences in the incidences of AEs,adverse drug reactions,or serious AEs among the 3 groups(P>0.05).Conclusion:GTC exhibited significant efficacy in improving patients'quality of life as well as neurological function and controlling hypertension.
|
关 键 词: | convalescent-phase of ischemic stroke primary hypertension Getong Tongluo Capsule total flavone of Radix Puerariae randomized controlled trial Chinese medicine |
本文献已被 维普 等数据库收录! |
| 点击此处可从《中国结合医学杂志》浏览原始摘要信息 |
|
点击此处可从《中国结合医学杂志》下载全文 |
|